Vertex to Acquire Alpine Immune Sciences for $4.9 Billion
- Posted by ISPE Boston
- On April 18, 2024
Vertex has announced it plans to acquire Seattle biotech Alpine Immune Sciences for $65 per share or approximately $4.9 billion in cash. Alpine is focused on discovering and developing innovative, protein-based immunotherapies. The transaction was unanimously approved by both the Vertex and Alpine Boards of Directors and is anticipated to close later this quarter. Alpine’s […]
Read More